
Burning Rock Biotech Investor Relations Material
Latest events

Q1 2024
Burning Rock Biotech

Q1 2025
6 Jun, 2025

Q4 2024
25 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Burning Rock Biotech Limited
Access all reports
Burning Rock Biotech Limited focuses on developing and providing next-generation sequencing-based cancer therapy selection tests. The company offers comprehensive genomic profiling services and products for cancer patients to guide treatment decisions. Its key services include liquid biopsy, tissue biopsy, and companion diagnostic development, aimed at improving clinical outcomes for cancer patients. Burning Rock Biotech serves sectors such as oncology, biotechnology, and personalized medicine, collaborating with medical institutions, pharmaceutical companies, and research organizations. The company is headquartered in Guangzhou, China, and its shares are listed on the NASDAQ.
Key slides for Burning Rock Biotech Limited


Q4 2024
Burning Rock Biotech Limited


Q4 2024
Burning Rock Biotech Limited
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
BNR
Country
🇺🇸 United States